Ethicon

If you’re looking for recent news about Ethicon and/or our business units and their products, our leaders, or our charitable giving, you’ll find it here.

May 10, 2011
Ethicon, Inc. Announces Availability of ETHICON SECURESTRAPTM 5MM Absorbable Strap Fixation Device

April 01, 2011
New CDC Guidelines Designate CHG-Impregnated Sponge As A Category 1B Recommendation Exclusively Based On Evidence Related To BIOPATCH®

URGENT VOLUNTARY PRODUCT RECALL BLAKE® Silicone Drain BLAKE® Silicone Drain Kit BLAKE® Cardio Connector J-VAC™ Reservoir J-VAC™ Drain Adapter.

February 02, 2011
URGENT VOLUNTARY PRODUCT RECALL DERMABOND® Topical Skin Adhesive DERMABOND® ProPen Topical Skin Adhesive.

November 11, 2010
PDS™ FLEXIBLE PLATE, A UNIQUE ABSORBABLE IMPLANT, FOR NASAL RECONSTRUCTION, NOW AVAILABLE IN THE U.S.

August 10, 2010
GYNECARE TVT EXACT™ Continence System Joins Ethicon’s GYNECARE TVT™ Family of Products Tension-free Support for Incontinence

July 07, 2010
Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company’s First Synthetic Internal Use Sealant

March 30, 2010
Ethicon Notifies U.S. Customers About NonSterile Product

January 21, 2010
Ethicon Completes Acquisition of Acclarent

December 16, 2009
Ethicon Announces Definitive Agreement to Acquire Acclarent

October 8, 2009
GYNECARE Morcellex* Tissue Morcellator - URGENT VOLUNTARY PRODUCT RECALL

August 20, 2009
Ethicon introduces new product enhancement and packaging for BIOPATCH® to improve ease of application for patients with catheters

March 12, 2009
GYNECARE PROLIFT+M™ Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery

January 23, 2009
Johnson & Johnson Completes Acquisition of Mentor Corporation

January 23, 2009
Johnson & Johnson Completes Tender Offer For Mentor Corporation

January 23, 2009
Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.

November 25, 2008
Ethicon Launches the Latest Innovation in Hernia Repair Platform; PROCEED™ Ventral Patch (PVP™ Device),
 
This information is provided for media professionals only. For media-related inquiries, please e-mail webmaster@ethus.jnj.com and your inquiry will be directed to the appropriate media relations person at Johnson & Johnson or its operating companies.